Status:

RECRUITING

Individualized Treatments in Adults With Relapsed/Refractory Cancers

Lead Sponsor:

Case Comprehensive Cancer Center

Collaborating Sponsors:

Florida International University

Community Foundation of Broward

Conditions:

Refractory Cancer

Relapsed Cancer

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

A personalized cancer medicine approach would address therapy resistance, cancer metastasis, and limited options after standard of care is exhausted in advanced cancer participants. This approach may ...

Detailed Description

Treatment itself will not be given as part of this trial. The results of the drug sensitivity test (DST) and genomic screening will be used to inform treating physician about participant-specific drug...

Eligibility Criteria

Inclusion

  • Participants aged 18 years or older at the time of enrollment on this study of any gender, race, or ethnicity.
  • Patients with suspected or confirmed diagnosis of recurrent or refractory cancer with no curative treatment options.
  • Participants who have undergone at least two lines of previous therapy.
  • Participants who are scheduled for or have recently had biopsy or tumor excised (solid tumors) or bone marrow aspirate (blood cancers) or who have scheduled or recently had paracentesis or thoracentesis performed.
  • Participants willing to have a blood draw or buccal swab done for the purposes of genetic testing.
  • Participants willing to sign informed consent.

Exclusion

  • Participants who do not have malignant tissue available and accessible.
  • Participants for whom the amount of excised malignant tissue is not sufficient for the ex vivo drug testing and/or genetic profiling.
  • Participants with newly diagnosed tumors and tumors that have high (\>90%) cure rate with safe standard therapy.

Key Trial Info

Start Date :

November 20 2023

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

November 1 2025

Estimated Enrollment :

36 Patients enrolled

Trial Details

Trial ID

NCT06024603

Start Date

November 20 2023

End Date

November 1 2025

Last Update

August 7 2025

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Florida International University

Miami, Florida, United States, 33199

2

Lerner College of Medicine, Cleveland Clinic Florida

Weston, Florida, United States, 33331